For 95% of patients who need treatment in 2026 or 2027, tirzepatide is the right choice not because it's the better drug on efficacy, but because it's the drug that exists right now
Vitek L, Jiraskova A, Malikova I, Dostalova G, Eremiasova L, Danzig V et al
EmSculpt\u00ae is the first FDA-Approved treatment shown to simultaneously build muscle and burn fat during a treatment session without a patient having to exert themselves
Further, miR-142-3p stimulates the ferroptosis in HBV-infected M1-type macrophages via SLC3A2, leading to the altered synthesis of GSH, malondialdehyde (MDA), and Fe2+ that potentially hastens the development of HCC (Hu et al., 2022)
These early-stage side effects are manageable and often resolve as the body acclimates to the medication's metabolic effects